Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer
Author:
Affiliation:
1. Bristol Myers Squibb, Princeton, NJ 08540, USA
2. HealthCore, Inc., Wilmington, DE 19801, USA
3. Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas, TX 75246, USA
Abstract
Funder
Bristol-Myers Squibb
Publisher
Future Medicine Ltd
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.futuremedicine.com/doi/pdf/10.2217/fon-2020-0516
Reference23 articles.
1. Targeted literature review of the global burden of gastric cancer
2. Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data
3. Treatment Patterns, Costs, and Survival among Medicare-Enrolled Elderly Patients Diagnosed with Advanced Stage Gastric Cancer: Analysis of a Linked Population-Based Cancer Registry and Administrative Claims Database
4. National Comprehensive Cancer Network. Clinical practice guidelines esophageal and esophagogastric junction cancers. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
5. Trastuzumab for the treatment of HER2- positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Allocation and value of curative oncological treatment in frail and fit older patients with esophageal cancer: An observational cohort study;Journal of Geriatric Oncology;2024-09
2. A Study on the Feasibility of Optimizing Gastric Cancer Screening to Reduce Screening Costs in China Using a Gradient Boosting Machine: A prospective, large-sample, single-center study;2024-02-20
3. Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma;Journal of Gastrointestinal Surgery;2023-11-06
4. Pembrolizumab alone or in combination with chemotherapy versus chemotherapy for advanced gastric cancer: A cost‐effectiveness analysis;Cancer Medicine;2023-09
5. Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA;Drugs - Real World Outcomes;2023-08-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3